Real-World Treatment Sequencing in Vulnerable Patients with Metastatic Colorectal Cancer: A Multicenter Retrospective Study.

Seiichiro MitaniYosuke KitoKaori HinoKentaro KawakamiNaoki IzawaFumiyasu HanamuraYoshiyuki YamamotoHirokazu ShojiAzusa KomoriShogen BokuKenji TsuchihashiKyoko KatoYoshikane NonagaseToshihiko MatsumotoMitsuhiro FurutaHiasto Kawakami

Published in: Targeted oncology (2023)

Second-line chemotherapy for vulnerable patients with mCRC showed clinically meaningful outcomes; however, few patients received second-line therapy, and survival among patients who received BSC was dismal.

Keyphrases

metastatic colorectal cancer
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
single cell
stem cells
type diabetes
squamous cell carcinoma
metabolic syndrome
clinical trial
locally advanced
adipose tissue
rectal cancer
weight loss